Matches in Wikidata for { <http://www.wikidata.org/entity/Q66405140> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- Q66405140 description "clinical trial" @default.
- Q66405140 description "ensayu clínicu" @default.
- Q66405140 description "klinisch onderzoek" @default.
- Q66405140 description "клінічне випробування" @default.
- Q66405140 name "A Study to Evaluate the Efficacy of Venetoclax in Relapsed/Refractory Participants With Chronic Lymphocytic Leukemia (CLL) Including Those With 17p Deletion or TP53 Mutation or Those Who Have Received a Prior B-cell Receptor Inhibitor." @default.
- Q66405140 name "A Study to Evaluate the Efficacy of Venetoclax in Relapsed/Refractory Participants With Chronic Lymphocytic Leukemia" @default.
- Q66405140 type Item @default.
- Q66405140 label "A Study to Evaluate the Efficacy of Venetoclax in Relapsed/Refractory Participants With Chronic Lymphocytic Leukemia (CLL) Including Those With 17p Deletion or TP53 Mutation or Those Who Have Received a Prior B-cell Receptor Inhibitor." @default.
- Q66405140 label "A Study to Evaluate the Efficacy of Venetoclax in Relapsed/Refractory Participants With Chronic Lymphocytic Leukemia" @default.
- Q66405140 prefLabel "A Study to Evaluate the Efficacy of Venetoclax in Relapsed/Refractory Participants With Chronic Lymphocytic Leukemia (CLL) Including Those With 17p Deletion or TP53 Mutation or Those Who Have Received a Prior B-cell Receptor Inhibitor." @default.
- Q66405140 prefLabel "A Study to Evaluate the Efficacy of Venetoclax in Relapsed/Refractory Participants With Chronic Lymphocytic Leukemia" @default.
- Q66405140 P1050 Q66405140-21BB0F66-4CA4-470A-84B0-EB27D02AE736 @default.
- Q66405140 P1132 Q66405140-A7B26E50-BBB8-4B3E-83CE-CCA41A026DBB @default.
- Q66405140 P1476 Q66405140-F6EED4DB-F719-4AC9-BE15-7CB00E046442 @default.
- Q66405140 P17 Q66405140-032F0F44-CFD1-45D3-9169-85E9B74978E2 @default.
- Q66405140 P17 Q66405140-0A130C89-C635-4EE3-BB8A-4FE1B72CB8E0 @default.
- Q66405140 P17 Q66405140-1B2407A8-9F34-4D63-A0AE-3F84CE7DF0FC @default.
- Q66405140 P17 Q66405140-3A3BC106-6F0C-4497-9112-3CB27FE1EB21 @default.
- Q66405140 P17 Q66405140-4DD0ACC9-E79B-4462-AA18-4CF074E37F93 @default.
- Q66405140 P17 Q66405140-4F0884B8-0D8E-4615-B411-29F6DD859371 @default.
- Q66405140 P17 Q66405140-6D009424-A88E-4B21-9061-A839EDD7C915 @default.
- Q66405140 P17 Q66405140-6F13FEF8-42A4-41A9-86E0-F77DCE92ADED @default.
- Q66405140 P17 Q66405140-7244B924-B126-40B3-BEF1-B3F5498D71EC @default.
- Q66405140 P17 Q66405140-88040A7D-5C8A-4082-9565-2C7090C6D24B @default.
- Q66405140 P17 Q66405140-9DD15B7A-CF74-4203-9BCB-2D6125FF1FF8 @default.
- Q66405140 P17 Q66405140-A8E88B9D-324C-410C-A461-40030A0C77B5 @default.
- Q66405140 P17 Q66405140-AC01E997-24D9-452D-9947-04D1AB5CDF16 @default.
- Q66405140 P17 Q66405140-AC0BED7D-7420-41A6-B7DF-B169C4E59B57 @default.
- Q66405140 P17 Q66405140-AC460DD8-4A6B-4F40-B5C4-4837128FC106 @default.
- Q66405140 P17 Q66405140-B9DAA9EB-4766-4245-949C-536A476B154F @default.
- Q66405140 P17 Q66405140-C5E15248-37A8-4376-88FE-BC798C17B84B @default.
- Q66405140 P17 Q66405140-DC827EED-AD4F-47E2-9236-F2AB0BA14C11 @default.
- Q66405140 P17 Q66405140-DD3D562A-6674-41D6-8260-ED48521E4823 @default.
- Q66405140 P17 Q66405140-E0C16F70-F7F5-4521-93A2-50C9972EA379 @default.
- Q66405140 P17 Q66405140-FC2478DD-A337-4A69-92BB-0BD7E0363C9B @default.
- Q66405140 P1813 Q66405140-423426BD-E847-410C-B6C4-8A8E58BA9038 @default.
- Q66405140 P2899 Q66405140-0931541D-8C31-4566-8435-42F00320EEAB @default.
- Q66405140 P3098 Q66405140-BFC922CC-A180-4994-8BE3-FC5FED2B0C97 @default.
- Q66405140 P31 Q66405140-417F56AB-2170-4192-93B4-495BD12E46E3 @default.
- Q66405140 P4135 Q66405140-96BD4ECF-AAB8-436B-8279-DE22C9EA0508 @default.
- Q66405140 P580 Q66405140-F5011CF9-F9B4-4F04-B1DF-8C369A9E0B4D @default.
- Q66405140 P582 Q66405140-5D9134B6-72A5-4126-8FF0-D84F694FBD43 @default.
- Q66405140 P6099 Q66405140-819C5B53-C6AF-426C-86A6-E7ED70AB2A6A @default.
- Q66405140 P8363 Q66405140-009324B7-52D0-4E05-B9DB-604192AD336C @default.
- Q66405140 P1050 Q29496 @default.
- Q66405140 P1132 "+257" @default.
- Q66405140 P1476 "Open-Label, Single-Arm, Phase 3b, Multi-Center Study Evaluating the Efficacy of Venetoclax (ABT-199) in Relapsed/Refractory Subjects With Chronic Lymphocytic Leukemia (CLL)" @default.
- Q66405140 P17 Q1183 @default.
- Q66405140 P17 Q142 @default.
- Q66405140 P17 Q145 @default.
- Q66405140 P17 Q16 @default.
- Q66405140 P17 Q183 @default.
- Q66405140 P17 Q20 @default.
- Q66405140 P17 Q27 @default.
- Q66405140 P17 Q29 @default.
- Q66405140 P17 Q30 @default.
- Q66405140 P17 Q31 @default.
- Q66405140 P17 Q33 @default.
- Q66405140 P17 Q34 @default.
- Q66405140 P17 Q35 @default.
- Q66405140 P17 Q38 @default.
- Q66405140 P17 Q39 @default.
- Q66405140 P17 Q40 @default.
- Q66405140 P17 Q41 @default.
- Q66405140 P17 Q43 @default.
- Q66405140 P17 Q45 @default.
- Q66405140 P17 Q55 @default.
- Q66405140 P17 Q801 @default.
- Q66405140 P1813 "VENICE I" @default.
- Q66405140 P2899 "+18" @default.
- Q66405140 P3098 "NCT02756611" @default.
- Q66405140 P31 Q30612 @default.
- Q66405140 P4135 "+99" @default.
- Q66405140 P580 "2016-06-22T00:00:00Z" @default.
- Q66405140 P582 "2022-03-05T00:00:00Z" @default.
- Q66405140 P6099 Q42824827 @default.
- Q66405140 P8363 Q78089383 @default.